Guggenheim Reiterates Neutral Rating for Itron (NASDAQ:ITRI)

Itron (NASDAQ:ITRI)‘s stock had its “neutral” rating reiterated by research analysts at Guggenheim in a note issued to investors on Friday,Benzinga reports.

ITRI has been the topic of several other research reports. Zacks Research cut Itron from a “hold” rating to a “strong sell” rating in a research note on Wednesday, January 28th. Stephens raised shares of Itron from an “equal weight” rating to an “overweight” rating and set a $130.00 price objective on the stock in a research report on Monday, November 3rd. JPMorgan Chase & Co. increased their target price on shares of Itron from $145.00 to $155.00 and gave the stock an “overweight” rating in a report on Thursday, October 16th. Weiss Ratings downgraded shares of Itron from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Monday, January 12th. Finally, Wall Street Zen cut shares of Itron from a “buy” rating to a “hold” rating in a research report on Wednesday, January 14th. Seven investment analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $136.10.

Itron Stock Performance

Shares of Itron stock opened at $95.74 on Friday. The company has a debt-to-equity ratio of 0.46, a current ratio of 2.17 and a quick ratio of 1.91. The firm has a market cap of $4.38 billion, a price-to-earnings ratio of 17.22, a price-to-earnings-growth ratio of 0.57 and a beta of 1.48. The stock’s 50-day moving average is $97.92 and its 200-day moving average is $111.60. Itron has a one year low of $90.11 and a one year high of $142.00.

Insider Activity

In other news, CFO Joan S. Hooper sold 948 shares of the business’s stock in a transaction dated Monday, November 24th. The shares were sold at an average price of $96.51, for a total transaction of $91,491.48. Following the transaction, the chief financial officer directly owned 87,446 shares in the company, valued at $8,439,413.46. The trade was a 1.07% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, SVP John F. Marcolini sold 553 shares of the company’s stock in a transaction dated Monday, November 24th. The shares were sold at an average price of $96.51, for a total transaction of $53,370.03. Following the completion of the sale, the senior vice president directly owned 13,843 shares in the company, valued at approximately $1,335,987.93. The trade was a 3.84% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last three months, insiders sold 2,971 shares of company stock valued at $286,731. 1.45% of the stock is owned by corporate insiders.

Institutional Trading of Itron

Several institutional investors and hedge funds have recently bought and sold shares of the business. EverSource Wealth Advisors LLC lifted its position in shares of Itron by 25.3% in the second quarter. EverSource Wealth Advisors LLC now owns 401 shares of the scientific and technical instruments company’s stock valued at $53,000 after buying an additional 81 shares during the last quarter. Amalgamated Bank raised its stake in Itron by 0.7% in the 3rd quarter. Amalgamated Bank now owns 13,060 shares of the scientific and technical instruments company’s stock valued at $1,627,000 after acquiring an additional 86 shares during the period. PFG Investments LLC lifted its holdings in Itron by 4.8% during the 3rd quarter. PFG Investments LLC now owns 2,059 shares of the scientific and technical instruments company’s stock valued at $256,000 after purchasing an additional 94 shares during the last quarter. Northwestern Mutual Wealth Management Co. lifted its holdings in Itron by 29.5% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 443 shares of the scientific and technical instruments company’s stock valued at $41,000 after purchasing an additional 101 shares during the last quarter. Finally, Elevation Point Wealth Partners LLC boosted its position in Itron by 3.5% during the second quarter. Elevation Point Wealth Partners LLC now owns 3,398 shares of the scientific and technical instruments company’s stock worth $447,000 after purchasing an additional 115 shares during the period. Institutional investors own 96.19% of the company’s stock.

About Itron

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.